Loading…
Reported covered position: 2008 Legislative Correspondent, Rep. Ric Keller
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · third_quarter · Q3
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Source: Senate LDA
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: VIATRIS INC.
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S4638 2025 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Ensuring Access to Lower-Cost Medicines for Seniors Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
National Defense Authorization Act for Fiscal Year 2025
Client: VIATRIS INC · Firm: VIATRIS INC.
S. 4638 - 2025 National Defense Authorization Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
COVID–19 Vaccine Dishonorable Discharge Prevention Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
COVID–19 Vaccine Dishonorable Discharge Prevention Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
Otto Warmbier Countering North Korean Censorship and Surveillance Act of 2021
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: VIATRIS INC.
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
IP Issues related to generic medicines Patent Settlements
S.2296 National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2026 · second_quarter · Q2
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements
S.2296 National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2026 · first_quarter · Q1
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Policy related to corporate governance
Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · fourth_quarter · Q4
S.2296 National Defense Authorization Act
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · third_quarter · Q3
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
S.2296 National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
2025 · second_quarter · Q2
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages The Medication Affordability and Patent Integrity Act
IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act
Trade issues related to generic medicines Pharmaceutical supply chain
2025 · first_quarter · Q1
Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act
IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act
2024 · fourth_quarter · Q4
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain
2024 · third_quarter · Q3
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicines for Seniors Act Drug Shortages S. 2780 and HR 5429, the Medication Affordability and Patent Integrity Act
Trade issues related to generic medicines Pharmaceutical supply chain
2024 · second_quarter · Q2
Trade issues related to generic medicines Pharmaceutical supply chain
IP Issues related to patient access to medicines Patent Settlements
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2024 · first_quarter · Q1
IP Issues related to generic medicines Patent Settlements
Trade issues related to generic medicines Pharmaceutical supply chain
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2023 · fourth_quarter · Q4
IP Issues related to generic medicines Patent Settlements
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages
2023 · third_quarter · Q3
IP Issues related to generic medicines Patent Settlements S.2780: Medication Affordability and Patient Integrity Act (U.S. Senate) H.R. 5429: Medication Affordability and Patient Integrity Act (U.S. House)
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act PEPFAR Reauthorization (Presidents Emergency Plan for AIDS Relief Reauthorization) S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act
2023 · second_quarter · Q2
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Trade issues related to generic medicines Pharmaceutical supply chain
IP Issues related to generic medicines Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Q1
Trade issues related to generic medicines Pharmaceutical supply chain
Corporate Tax Policy
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
2022 · fourth_quarter · Q4
Trade issues related to generic medicines Pharmaceutical supply chain
VA Access to affordable medicines
Corporate Tax Policy
2022 · third_quarter · Q3
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022
Trade issues related to generic medicines Pharmaceutical supply chain
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals
2022 · second_quarter · Q2
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Corporate Tax Policy
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - Build Back Better Act; Part D Formulary Design and Generic Drug Tiering S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. FDA facility inspections Medicate incentives for biosimilar utilization Complex Generic Drug Approvals
2022 · first_quarter · Q1
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act H.R. 6973, Enhanced Access to Affordable Medicines Act of 2022 H.R. 7032, Increasing Transparency in Generic Drug Applications Act of 2022
Corporate Tax Policy
2021 · fourth_quarter · Q4
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Corporate Tax Policy
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act
2021 · third_quarter · Q3
Trade issues related to generic medicines Pharmaceutical supply chain
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs H.R. 1319 - American Rescue Plan Act FDA facility inspections Medicare incentives for biosimilar utilization H.R. 4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act FY2022 Labor, HHS, Education, and Related Agencies Appropriations Bill Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability
2021 · second_quarter · 2A
Corporate Tax Policy
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements USPTO subject matter eligibility - Section 101
Trade issues related to generic medicines Pharmaceutical supply chain S. 1260 - the U.S. Innovation and Competition Act
2021 · second_quarter · Q2
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Trade issues related to generic medicines Pharmaceutical supply chain S. 1260 - the U.S. Innovation and Competition Act
Corporate Tax Policy
2021 · first_quarter · Q1
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Trade issues related to generic medicines Access to global pharmaceutical supply chain and incentives for domestic manufacturing
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs H.R. 1319 - American Rescue Plan Act FDA facility inspections Medicare incentives for biosimilar utilization FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill FY2022 Labor, HHS, Education, and Related Agencies Appropriations Bill Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals Electronic Labeling of Prescription Drugs
2020 · fourth_quarter · 4A
Trade issues related to generic medicines Access to global pharmaceutical supply chain and incentives for domestic manufacturing
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543 - Prescription Drug Pricing Reduction Act S. 1416 - Affordable Prescriptions for Patients Act S. 1895 - Lower Health Care Costs Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act H.R. 6179 - Increasing Access to Biosimilars Act of 2020 S. 2723 - Mitigating Emergency Drug Shortages Act H.R. 5304 - PBM Transparency in Prescription Drug Costs Act H.R. 748 - CARES Act H.R. 6431 - Made in America Emergency Preparedness Act S. 4134 - Increasing Access to Biosimilars Act of 2020 Electronic Labeling of Prescription Drugs H.R. 133 - Consolidated Appropriations Act, 2021 H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act H.R. 8644 - Secure Americas Medicine Act of 2020 H.R. 8588 - Improving the American Drug Supply Chain Act of 2020
2020 · fourth_quarter · Q4
Trade issues related to generic medicines Access to global pharmaceutical supply chain and incentives for domestic manufacturing
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543 - Prescription Drug Pricing Reduction Act S. 1416 - Affordable Prescriptions for Patients Act S. 1895 - Lower Health Care Costs Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act H.R. 6179 - Increasing Access to Biosimilars Act of 2020 S. 2723 - Mitigating Emergency Drug Shortages Act H.R. 5304 - PBM Transparency in Prescription Drug Costs Act H.R. 748 - CARES Act H.R. 6431 - Made in America Emergency Preparedness Act S. 4134 - Increasing Access to Biosimilars Act of 2020 Electronic Labeling of Prescription Drugs H.R. 133 - Consolidated Appropriations Act, 2021 H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act H.R. 8644 - Secure Americas Medicine Act of 2020 H.R. 8588 - Improving the American Drug Supply Chain Act of 2020
2020 · third_quarter · Q3
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Trade issues related to generic medicines Access to global pharmaceutical supply chain and incentives for domestic manufacturing
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements
2020 · second_quarter · Q2
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543 - Prescription Drug Pricing Reduction Act S. 1416 - Affordable Prescriptions for Patients Act S. 1895 - Lower Health Care Costs Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act H.R. 6179 - Increasing Access to Biosimilars Act of 2020 S. 2723 - Mitigating Emergency Drug Shortages Act H.R. 5304 - PBM Transparency in Prescription Drug Costs Act H.R. 748 - CARES Act H.R. 6431 - Made in America Emergency Preparedness Act
2020 · first_quarter · Q1
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543, Prescription Drug Pricing Reduction Act S. 1416, Affordable Prescriptions for Patients Act S. 1895 Lower Health Care Costs Act of 2019 H.R. 3- Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act H.R. 6179 - Increasing Access to Biosimilars Act of 2020 S. 2723 - Mitigating Emergency Drug Shortages Act H.R. 5304 - PBM Transparency in Prescription Drug Costs Act H.R. 748 - CARES Act
2019 · fourth_quarter · Q4
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Trade issues related to generic medicines
2019 · third_quarter · Q3
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Policy and oversight related to proxy advisory firms
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements
2019 · second_quarter · Q2
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Risk Evaluation and Mitigation Strategies (REMS), H.R. 985 - FAST Generics Act of 2019, S. 340, H.R. 965 - CREATES Act of 2019 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics Medicare reimbursement for biosimilars, Pass through payments for biosimilars S. 1416, Affordable Prescriptions for Patients Act Senate HELP Committee Lower Health Care Costs Act of 2019 FY 2020 House/Senate Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies H.R. 938 - BLOCKING Act of 2019 H.R. 1520 - The Purple Book Continuity Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs, Section 101 Reform of the Patent Act S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019, S.1416 - Affordable Prescriptions for Patients Act of 2019, Patent Settlements
2019 · first_quarter · Q1
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs, S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019, Patent Settlements
Trade issues related to generic medicines
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Risk Evaluation and Mitigation Strategies (REMS), H.R. 985 - FAST Generics Act of 2019, S. 340, H.R. 965 - CREATES Act of 2019 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics Medicare reimbursement for biosimilars, Pass through payments for biosimilars H.R. 938 - BLOCKING Act of 2019 H.R. 1520 - The Purple Book Continuity Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 CY2020 CMS Call Letter
2018 · fourth_quarter · Q4
Trade issues related to generic medicines
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs, Hatch-Waxman Integrity Act of 2018, Patent Settlements
2018 · third_quarter · Q3
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Risk Evaluation and Mitigation Strategies (REMS), H.R. 2051 - FAST Generics Act of 2017, S.974, H.R. 2212 - CREATES Act of 2017 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics Medicare reimbursement for biosimilars, Pass through payments for biosimilars
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Trade issues related to generic medicines
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, White House Office
S.2296 National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
S4638 2025 National Defense Authorization Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 4638 - 2025 National Defense Authorization Act
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
IP Issues related to patient access to medicines Patent Settlements S 2220, The PREVAIL Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 5376 - the Inflation Reduction Act of 2022; from the 117th Congress Part D Formulary Design and Generic Drug Tiering S. 4338 - Increasing Transparency in Generic Drug Applications Act, (S. 775); from the 117th Congress HR1503, Prescription Information Modernization Act Implementation of the Inflation Reduction Act Presidents Emergency Plan for AIDS Relief Reauthorization
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Corporate Tax Policy
VA Access to affordable medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Trade issues related to generic medicines Pharmaceutical supply chain
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Trade issues related to generic medicines Pharmaceutical supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements
Corporate Tax Policy
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs H.R. 1319 - American Rescue Plan Act FDA facility inspections Medicare incentives for biosimilar utilization H.R. 4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act FY2022 Labor, HHS, Education, and Related Agencies Appropriations Bill Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements USPTO subject matter eligibility - Section 101
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs H.R. 1319 - American Rescue Plan Act FDA facility inspections Medicare incentives for biosimilar utilization H.R. 4356 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act FY2022 Labor, HHS, Education, and Related Agencies Appropriations Bill Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements USPTO subject matter eligibility - Section 101
Corporate Tax Policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements Patent Reform
H.R. 6930 - Made in America Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R. 6930 - Made in America Act
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements Patent Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543 - Prescription Drug Pricing Reduction Act S. 1416 - Affordable Prescriptions for Patients Act S. 1895 - Lower Health Care Costs Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act H.R. 6179 - Increasing Access to Biosimilars Act of 2020 S. 2723 - Mitigating Emergency Drug Shortages Act H.R. 5304 - PBM Transparency in Prescription Drug Costs Act H.R. 748 - CARES Act H.R. 6431 - Made in America Emergency Preparedness Act S. 4134, Increasing Access to Biosimilars Act of 2020 Electronic Labeling of Prescription Drugs
H.R. 6930 - Made in America Act Tax incentives for domestic manufacturing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R. 6930 - Made in America Act Tax incentives for domestic manufacturing
Trade issues related to generic medicines Access to global pharmaceutical supply chain and incentives for domestic manufacturing
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
Trade issues related to generic medicines Access to global pharmaceutical supply chain
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs S.344, H.R. 990 - Hatch-Waxman Integrity Act of 2019 Patent Settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Risk Evaluation and Mitigation Strategies (REMS), H.R. 985 - FAST Generics Act of 2019, S. 340, H.R. 965 - CREATES Act of 2019 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics, S. 2103 - Affordable Insulin Approvals Now Act, H.R. 5444 - Lower Insulin Costs Now Act Medicare reimbursement for biosimilars, shared savings for Part B providers S.2543, Prescription Drug Pricing Reduction Act S. 1416, Affordable Prescriptions for Patients Act S. 1895 Lower Health Care Costs Act of 2019 H.R. 3- Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering H.R. 4913 - Ensuring Access to Lower-Cost Medicines for Seniors Act S. 64, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act H.R. 4455 - BIOSIM Act H.R. 4629 - Star Rating for Biosimilars Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugsRisk Evaluation and Mitigation Strategies (REMS), H.R. 985 - FAST Generics Act of 2019, S. 340, H.R. 965 - CREATES Act of 2019 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics Medicare reimbursement for biosimilars, Pass through payments for biosimilars S.2543, Prescription Drug Pricing Reduction Act S. 1416, Affordable Prescriptions for Patients Act Senate HELP Committee Lower Health Care Costs Act of 2019 FY 2020 House/Senate Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies H.R. 3- Lower Drug Costs Now Act of 2019 H.R. 938 - BLOCKING Act of 2019 H.R. 1520 - The Purple Book Continuity Act of 2019 H.R. 1499 - The Protecting Consumer Access to Generic Drugs Act of 2019 Part D Formulary Design and Generic Drug Tiering
Trade issues related to generic medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Trade issues related to generic medicines
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Medicaid Rebate provision of the Bipartisan Budget Act of 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Risk Evaluation and Mitigation Strategies (REMS), H.R. 2051 - FAST Generics Act of 2017, S.974, H.R. 2212 - CREATES Act of 2017 Biologics Price Competition and Innovation Act (BPCIA) transition provisions affecting Insulins, complex generics Medicare reimbursement for biosimilars, Pass through payments for biosimilars
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, White House Office